{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T12:54:18Z","timestamp":1765976058848},"reference-count":25,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,28]],"date-time":"2015-04-28T00:00:00Z","timestamp":1430179200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005561","name":"DHHS","doi-asserted-by":"publisher","award":["R43CA177067"],"award-info":[{"award-number":["R43CA177067"]}],"id":[{"id":"10.13039\/100005561","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002387","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002387","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005561","name":"DHHS","doi-asserted-by":"publisher","award":["P30CA014089","U01-CA-151837","R01CA-154471","R21-CA-164098"],"award-info":[{"award-number":["P30CA014089","U01-CA-151837","R01CA-154471","R21-CA-164098"]}],"id":[{"id":"10.13039\/100005561","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002387","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002387","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001368","name":"V-Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001368","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Nautica Triathlon"},{"name":"Ronald McDonald House Charities of Southern California"},{"name":"NSF-CHE","award":["1308485"],"award-info":[{"award-number":["1308485"]}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["1DP2OD007246"],"award-info":[{"award-number":["1DP2OD007246"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ebiomedicine.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.ebiom.2015.04.016","type":"journal-article","created":{"date-parts":[[2015,5,2]],"date-time":"2015-05-02T20:47:32Z","timestamp":1430599652000},"page":"649-659","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Development of Polypeptide-based Nanoparticles for Non-viral Delivery of CD22 RNA Trans-splicing Molecule as a New Precision Medicine Candidate Against B-lineage ALL"],"prefix":"10.1016","volume":"2","author":[{"given":"Fatih M.","family":"Uckun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lloyd G.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjive","family":"Qazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorothea E.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianjun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ebiom.2015.04.016_bb0005","doi-asserted-by":"crossref","first-page":"e80070","DOI":"10.1371\/journal.pone.0080070","article-title":"Differential effects of selective inhibitors targeting the PI3K\/AKT\/mTOR pathway in acute lymphoblastic leukemia","volume":"8","author":"Badura","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2015.04.016_bb0010","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/anie.201104262","article-title":"Reactive and bioactive cationic \u03b1-helical polypeptide template for nonviral gene delivery","volume":"51","author":"Gabrielson","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ebiom.2015.04.016_bb0015","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1200\/JCO.2005.04.5856","article-title":"Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12months of the completion of primary therapy: Children's Oncology Group Study CCG-1941","volume":"24","author":"Gaynon","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ebiom.2015.04.016_bb0020","doi-asserted-by":"crossref","first-page":"8705","DOI":"10.1038\/srep08705","article-title":"Trans-splicing repair of mutant p53 suppresses the growth of hepatocellular carcinoma cells in vitro and in vivo","volume":"5","author":"He","year":"2015","journal-title":"Sci. Rep."},{"issue":"19","key":"10.1016\/j.ebiom.2015.04.016_bb0025","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.1182\/blood-2011-04-345595","article-title":"Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies","volume":"118","author":"Hogan","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2015.04.016_bb0030","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/ncomms1209","article-title":"Ionic polypeptides with unusual helical stability","volume":"2","author":"Lu","year":"2011","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ebiom.2015.04.016_bb0035","article-title":"CD22 Exon 12 deletion is a characteristic genetic defect of therapy-refractory clones in paediatric acute lymphoblastic leukaemia","author":"Ma","year":"2011","journal-title":"Br. J. Haematol."},{"issue":"20","key":"10.1016\/j.ebiom.2015.04.016_bb0040","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/sj.gt.3302596","article-title":"Progress & prospects: reprograming gene expression by trans-splicing","volume":"12","author":"Mitchell","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.ebiom.2015.04.016_bb0045","article-title":"Targeting the PI3K\/Akt\/mTOR signaling pathway in B-precursor acute lymphoblastic leukemia and its therapeutic potential","author":"Neri","year":"2013","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.ebiom.2015.04.016_bb0050","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1053\/j.seminoncol.2008.07.008","article-title":"Progress in childhood cancer: 50years of research collaboration, a report from the Children's Oncology Group","volume":"35","author":"O'Leary","year":"2008","journal-title":"Semin. Oncol."},{"issue":"6","key":"10.1016\/j.ebiom.2015.04.016_bb0055","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1182\/blood-2012-05-378943","article-title":"Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?","volume":"120","author":"Pui","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2015.04.016_bb0060","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nm1086","article-title":"Trans-splicing repair of CD40 ligand deficiency results in naturally regulated correction of a mouse model of hyper-IgM X-linked immunodeficiency","volume":"10","author":"Tahara","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.ebiom.2015.04.016_bb0065","doi-asserted-by":"crossref","first-page":"16852","DOI":"10.1073\/pnas.1007896107","article-title":"CD22 Exon 12 deletion as a novel pathogenic mechanism of human B-precursor leukemia","volume":"107","author":"Uckun","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"21","key":"10.1016\/j.ebiom.2015.04.016_bb0070","doi-asserted-by":"crossref","first-page":"4348","DOI":"10.1182\/blood-2012-11-470633","article-title":"Nanoscale liposomal formulation of a SYK P-site inhibitor against B-precursor leukemia","volume":"121","author":"Uckun","year":"2013","journal-title":"Blood"},{"issue":"2\u20133","key":"10.1016\/j.ebiom.2015.04.016_bb0075","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ebiom.2014.10.013","article-title":"A rationally designed CD22\u0394E12-siRNA nanoparticle for RNAi therapy in B-lineage lymphoid malignancies","volume":"1","author":"Uckun","year":"2014","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.ebiom.2015.04.016_bb0080","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ebiom.2014.10.019","article-title":"A previously unknown unique challenge for inhibitors of Syk Atp-binding site: role of Syk as a cell cycle checkpoint regulator","volume":"1","author":"Uckun","year":"2014","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ebiom.2015.04.016_bb0085","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1039\/C4IB00221K","article-title":"CD22\u0394E12 as a molecular target for corrective repair using RNA trans-splicing: anti-leukemic activity of a rationally designed RNA trans-splicing molecule","volume":"7","author":"Uckun","year":"2015","journal-title":"Integr. Biol. (Camb.)"},{"issue":"3","key":"10.1016\/j.ebiom.2015.04.016_bb0095","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1172\/JCI76610","article-title":"Recombinant human CD19L-sTRAIL protein effectively targets B-precursor acute lymphoblastic leukemia","volume":"125","author":"Uckun","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ebiom.2015.04.016_bb0100","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ebiom.2015.04.005","article-title":"Liposomal nanoparticles of a spleen tyrosine kinase P-site inhibitor amplify the potency of low dose total body irradiation against aggressive B-precursor leukemia and yield superior survival outcomes in mice","volume":"2","author":"Uckun","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ebiom.2015.04.016_bb0090","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.13306","article-title":"CD22\u0394E12 as a molecular target for RNAi therapy","author":"Uckun","year":"2015","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ebiom.2015.04.016_bb0105","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ebiom.2015.02.008","article-title":"Low dose total body irradiation combined with recombinant CD19-ligand\u00d7soluble TRAIL fusion protein is highly effective against radiation-resistant B-precursor acute lymphoblastic leukemia in mice","volume":"2","author":"Uckun","year":"2015","journal-title":"EBiomedicine"},{"key":"10.1016\/j.ebiom.2015.04.016_bb0110","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1002\/adma.201205088","article-title":"Non-viral gene delivery via membrane penetrating, mannose-targeting supramolecular self-assembled nanocomplexes","volume":"25","author":"Yin","year":"2013","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ebiom.2015.04.016_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/anie.201209991","article-title":"Supramolecular self-assembled nanoparticles (SSNPs) mediate oral delivery of therapeutic TNF-\u03b1 siRNA against systemic inflammation","author":"Yin","year":"2013","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ebiom.2015.04.016_bb0120","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.biomaterials.2013.09.090","article-title":"Maximizing gene delivery efficiencies of cationic helical polypeptides via balanced membrane penetration and cellular targeting","volume":"35","author":"Zheng","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.ebiom.2015.04.016_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2015.02.014","article-title":"Redox-responsive, reversibly-crosslinked thiolated cationic helical polypeptides for efficient siRNA encapsulation and delivery","author":"Zheng","year":"2015","journal-title":"J. Control. Release"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396415300037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396415300037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T23:55:44Z","timestamp":1537660544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396415300037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S2352396415300037"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2015.04.016","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of Polypeptide-based Nanoparticles for Non-viral Delivery of CD22 RNA Trans-splicing Molecule as a New Precision Medicine Candidate Against B-lineage ALL","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2015.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}